Surmount
Automated Investing & Portfolio Tools
Cerebras's share price already assumes years of flawless execution, so investors can be right about the company long term and still lose money. Two customers make up 86% of revenue, it posted a $146 million operating loss in 2025, its GAAP profit came from accounting gains, and it trades at 111x revenue. The wafer-scale technology, 15x faster AI inference and $20B+ OpenAI compute deal make the bull case real, but the price leaves no margin for early-stage setbacks. x.comÂ
Cerebras may be the most important AI infrastructure IPO since Arm, because its wafer-scale chips deliver much faster, cheaper inference as AI spending shifts from training to deployment. 2025 revenue rose 76% to $510M, swinging to $237.8M net income. OpenAI agreed to buy up to 750MW of its compute over three years, roughly $2B a year if recognized over five years, nearly 4x 2025 revenue, and AWS signed a multi-year deal. With G42's $1.43B commitments, analysts see $3-4B revenue by 2028. x.comÂ
Cerebras is difficult for retail investors to understand, and management has not done a great job explaining its business since going public. It deserves more attention as the most direct AI IPO of 2026, but going long Cerebras is hard to justify when Nvidia can be owned instead. x.comÂ
Cerebras at over 100x sales with execution hurdles is not a low-risk buy, so it is better to sit out for now. It is a pure AI hardware bet: if wafer-scale chips take meaningful share from NVIDIA and revenue grows 2-4x or more in two years, the roughly $237 price could look reasonable long term. It suits only aggressive growth investors who can stomach 30-50% swings. x.comÂ
Cerebras' inference opportunity can support substantial long-term upside if installed capacity grows from 60MW to 3.2GW by 2031 and OpenAI renews after 2028. The risk-adjusted model puts 2031 value at $485-$700 per share while assuming rivals narrow its speed premium and customers and partners fund most capex. If those assumptions fail, capex, dilution and valuation risk rise. x.comÂ
Cerebras is wildly overvalued after opening its debut up 102%, at about 157.8x sales. FY25 revenue was $510M against 215.23M shares outstanding, and its $150M net income was not related to its core business. Late buyers risk becoming bag holders. x.com x.comÂ
Cerebras still needs to come down further before it is worth buying. IPO stocks often rise sharply at first, then fall, and can take a long time to return to their original value, so entering at an expensive price right after the IPO is unappealing. The view is not entirely negative on Cerebras, and it should not be called a direct Nvidia rival. x.comÂ
Cerebras looks attractive because the short report's two-year wafer-life thesis rests on unvalidated reliability assumptions, not representative failure data. Energy per useful token, lower warranty utilization and ordinary repair accounting also undercut its financial conclusions. OpenAI has integrated Cerebras into production; AMD and AWS have announced integrations, while Oracle plans 2027 availability for ultra-fast inference, adding commercial validation despite the report. x.com x.comÂ
Cerebras is absurdly valued at about $50 billion against roughly $865 million of full-year revenue and $194 million for the quarter. Overpriced listings like this will hurt young investors and push them to give up on stock investing. x.comÂ
Cerebras is a name to stay far away from. It tanked after OpenAI said its new chip with Broadcom outperforms Nvidia's, underlining how heavily Cerebras is tied to OpenAI, a dependence that hurt Oracle. It is also a recent IPO, a good share of its stock is owned by OpenAI insiders, and it is insanely volatile. x.comÂ
Cerebras Systems offers the fastest AI inference chip available, a single wafer-sized processor with the model's memory on the chip, running inference several times faster than GPU systems. It has a $25.4B backlog, about 30x this year's revenue, partnerships with OpenAI, AMD and AWS, and no exposure to rising HBM prices. Concerns: a 14.2% GAAP gross margin, about $600M of free cash flow burned in the first half, roughly 80% of backlog tied to OpenAI, and about 171M shares unlocking in November. … Show more
Cerebras is a stock to avoid in a cash-out environment where companies, executives, employees and early investors are selling to buyers. Per a WSJ report cited by @wallstengine, Nvidia's AI chip business is over 400x larger than Cerebras and growing nearly as fast, yet Cerebras trades around 134x trailing revenue, more than 5x Nvidia's multiple. x.comÂ
